BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 27982703)

  • 1. Revisiting Repurposing.
    Sharlow ER
    Assay Drug Dev Technol; 2016 Dec; 14(10):554-556. PubMed ID: 27982703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing Drugs in Oncology: Next Steps.
    Verbaanderd C; Meheus L; Huys I; Pantziarka P
    Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia.
    Lago SG; Bahn S
    ACS Chem Neurosci; 2019 Jan; 10(1):58-78. PubMed ID: 29944339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on Drug Repurposing: Re-written saga of the drug's fate.
    Gns HS; Gr S; Murahari M; Krishnamurthy M
    Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repurposing: a promising tool to accelerate the drug discovery process.
    Parvathaneni V; Kulkarni NS; Muth A; Gupta V
    Drug Discov Today; 2019 Oct; 24(10):2076-2085. PubMed ID: 31238113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics.
    Talevi A; Bellera CL
    Expert Opin Drug Discov; 2020 Apr; 15(4):397-401. PubMed ID: 31847616
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacodynamics and Systems Pharmacology Approaches to Repurposing Drugs in the Wake of Global Health Burden.
    Bai JPF
    J Pharm Sci; 2016 Oct; 105(10):3007-3012. PubMed ID: 27522921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connections in pharmacology: innovation serving translational medicine.
    Montero-Melendez T; Perretti M
    Drug Discov Today; 2014 Jul; 19(7):820-3. PubMed ID: 24316023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Drug Repurposing: Current Trends.
    Karaman B; Sippl W
    Curr Med Chem; 2019; 26(28):5389-5409. PubMed ID: 29848268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies.
    Jain P; Jain SK; Jain M
    Curr Mol Med; 2021; 21(2):111-132. PubMed ID: 32560606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mining small-molecule screens to repurpose drugs.
    Swamidass SJ
    Brief Bioinform; 2011 Jul; 12(4):327-35. PubMed ID: 21715466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery.
    Chen H; Wu J; Gao Y; Chen H; Zhou J
    Curr Top Med Chem; 2016; 16(19):2107-14. PubMed ID: 26881709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery.
    Pillaiyar T; Meenakshisundaram S; Manickam M; Sankaranarayanan M
    Eur J Med Chem; 2020 Jun; 195():112275. PubMed ID: 32283298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines.
    Jin G; Wong ST
    Drug Discov Today; 2014 May; 19(5):637-44. PubMed ID: 24239728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing existing drugs for new AMPK activators as a strategy to extend lifespan: a computer-aided drug discovery study.
    Mofidifar S; Sohraby F; Bagheri M; Aryapour H
    Biogerontology; 2018 Apr; 19(2):133-143. PubMed ID: 29335817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis.
    Janes J; Young ME; Chen E; Rogers NH; Burgstaller-Muehlbacher S; Hughes LD; Love MS; Hull MV; Kuhen KL; Woods AK; Joseph SB; Petrassi HM; McNamara CW; Tremblay MS; Su AI; Schultz PG; Chatterjee AK
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10750-10755. PubMed ID: 30282735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repurposing for antimicrobial discovery.
    Farha MA; Brown ED
    Nat Microbiol; 2019 Apr; 4(4):565-577. PubMed ID: 30833727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repackaging FDA-approved drugs for degenerative diseases: promises and challenges.
    Cummings JL; Zhong K
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):161-5. PubMed ID: 24502586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The urgent need for pan-antiviral agents: from multitarget discovery to multiscale design.
    V Kleandrova V; Speck-Planche A
    Future Med Chem; 2021 Jan; 13(1):5-8. PubMed ID: 33225723
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrative cancer pharmacogenomics to establish drug mechanism of action: drug repurposing.
    El-Hachem N; Ba-Alawi W; Smith I; Mer AS; Haibe-Kains B
    Pharmacogenomics; 2017 Nov; 18(16):1469-1472. PubMed ID: 29057710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.